Kiwifruit grower Seeka says the effects of the PSA kiwifruit vine disease could result in a loss this financial year, because of a writedown in the value of its assets.
It now forecasts pre-tax earnings of between $20 - $21 million for the nine months to the end of December, compared with $19.8 million for the same time last year.
But Seeka says the impact of PSA is likely to lead to write-downs in land, building and biological assets which could result in a net loss.
The company is also preparing for a smaller harvest in 2012.
It says PSA continues to cause uncertainty in the industry and the board will maintain a fiscally prudent approach with repayment of debt a priority.
